Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers (Q44953696)

7 December 2017

Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers (English)

1 reference

Adaptive radiation therapy

7 December 2017

0 references

author name string

Dobrowsky W

series ordinal

1

1 reference

PubMed ID

11054514

7 December 2017

Naudé J

series ordinal

2

1 reference

7 December 2017

1 November 2000

1 reference

Radiotherapy and Oncology

7 December 2017

1 reference

7 December 2017

57

1 reference

7 December 2017

2

1 reference

7 December 2017

119-124

1 reference

Altered fractionation trials in head and neck cancer

7 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900233-4

7 January 2021

The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900233-4

7 January 2021

Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900233-4

7 January 2021

A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900233-4

7 January 2021

Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale Mitomycin Randomized Trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900233-4

7 January 2021

Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900233-4

7 January 2021

A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900233-4

7 January 2021

Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900233-4

7 January 2021

Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900233-4

7 January 2021

Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: (preliminary report) by the Radiation Therapy Onc

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900233-4

7 January 2021

An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900233-4

7 January 2021

Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900233-4

7 January 2021

Radiotherapy with thrice-a-day fractionation in a short overall time: Clinical experiences

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900233-4

7 January 2021

Meta-analysis of chemotherapy in head and neck cancer: individual patient data vs literature data

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900233-4

7 January 2021

Continuous hyperfractionated accelerated radiotherapy in locally advanced carcinoma of the head and neck region

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900233-4

7 January 2021

Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900233-4

7 January 2021

The hazard of accelerated tumor clonogen repopulation during radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900233-4

7 January 2021

10.1016/S0167-8140(00)00233-4

Identifiers

DOI

1 reference

7 December 2017

1 reference

PubMed ID

11054514